Ophthalmology and Visual Impairment Studies, Tactile and Sensory Interactions, Retinopathy of Prematurity Studies · 2020 · The Lancet Global HealthRupert Bourne,
Jaimie D Steinmetz,
Seth Flaxman,
Paul Svitil Briant,
Hugh R. Taylor,
Serge Resnikoff,
Robert J. Casson,
Amir Abdoli,
Eman Abu‐Gharbieh,
Ashkan Afshin,
Hamid Ahmadieh,
Yonas Akalu,
Alehegn Aderaw Alamneh,
Wondu Alemayehu,
Ahmed Samir Alfaar,
Vahid Alipour,
Etsay Woldu Anbesu,
Sofia Androudi,
Jalal Arabloo,
Aries Arditi,
Malke Asaad,
Eleni Bagli,
Atif Amin Baig,
Till Bärnighausen,
Maurízio Battaglia Parodi,
Akshaya Srikanth Bhagavathula,
Nikha Bhardwaj,
Pankaj Bhardwaj,
Krittika Bhattacharyya,
Ali Bijani,
Mukharram M. Bikbov,
Michele Bottone,
Tasanee Braithwaite,
Alain M. Bron,
Zahid A Butt,
Ching‐Yu Cheng,
Dinh‐Toi Chu,
Maria Vittoria Cicinelli,
João Coelho,
Baye Dagnew,
Xiaochen Dai,
Reza Dana,
Lalit Dandona,
Rakhi Dandona,
Monte A. Del Monte,
Jenny P Deva,
Daniel Díaz,
Shirin Djalalinia,
Laura E. Dreer,
Joshua R. Ehrlich,
Leon B. Ellwein,
Mohammad Hassan Emamian,
Arthur Gustavo Fernandes,
Florian Fischer,
David S. Friedman,
João M. Furtado,
Abhay Gaidhane,
Shilpa Gaidhane,
Gus Gazzard,
Berhe Gebremichael,
Ronnie George,
Ahmad Ghashghaee,
Mahaveer Golechha,
Samer Hamidi,
Billy R. Hammond,
M. Elizabeth Hartnett,
Risky Kusuma Hartono,
Simon I Hay,
Golnaz Heidari,
Hung Chak Ho,
Chi Linh Hoang,
Mowafa Househ,
Segun Emmanuel Ibitoye,
Irena Ilić,
Milena Ilić,
April Ingram,
Seyed Sina Naghibi Irvani,
Ravi Prakash Jha,
Rim Kahloun,
Himal Kandel,
Ayele Semachew Kasa,
John H. Kempen,
Maryam Keramati,
Moncef Khairallah,
Ejaz Ahmad Khan,
Rohit C Khanna,
Mahalaqua Nazli Khatib,
Judy E. Kim,
Yun Jin Kim,
Sezer Kısa,
Adnan Kısa,
Ai Koyanagi,
Om Kurmi,
Van Charles Lansingh,
Janet L Leasher,
Nicolas Leveziel,
Hans Limburg,
Marek Majdán,
Navid Manafi,
Kaweh Mansouri Background To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990–2020, and forecasts for 2050. Methods We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. Only studies with samples representative of the population and with clearly defined visual acuity testing protocols were included. We fitted hierarchical models to estimate 2020 prevalence (with 95% uncertainty intervals [UIs]) of mild vision impairment (presenting visual acuity ≥6/18 and
